CSF p-tau205: a biomarker of Alzheimer’s disease progression and biological staging
8 September, 2026
Mol Psychiatry (2026). https://doi.org/10.1038/s41380-026-03838-3
Read the articlePlasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease
1 July, 2026
JAMA Neurol. 2026 Jul 1;83(7):654-666. doi: 10.1001/jamaneurol.2026.1405.PMID: 42189519
Read the articleThe Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline
9 June, 2026
Neurology. 2026 Jun 9;106(11):e214983. doi: 10.1212/WNL.0000000000214983. Epub 2026 May 14.PMID: 42133909
Read the articleProteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer’s disease
15 May, 2026
Nat Aging. 2026 May;6(5):1138-1157. doi: 10.1038/s43587-026-01123-0. Epub 2026 May 15.PMID: 42141098
Read the articleA deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
31 March, 2026
Nat Med. 2026 Mar 31. doi: 10.1038/s41591-026-04303-y. Online ahead of print.PMID: 41917159
Read the articleEligibility for amyloid targeting therapies among primary care patients with cognitive symptoms
21 March, 2026
Alzheimers Res Ther. 2026 Mar 21;18(1):77. doi: 10.1186/s13195-026-02019-2.PMID: 41865008
Read the articleIntegration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer’s disease: a prospective cohort study
18 March, 2026
Lancet Neurol. 2026 Apr;25(4):357-367. doi: 10.1016/S1474-4422(26)00029-3.PMID: 41864233
Read the articleIdentification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling
16 March, 2026
Nat Aging. 2026 Mar;6(3):703-721. doi: 10.1038/s43587-026-01081-7. Epub 2026 Feb 24.PMID: 41735646
Read the articleTreatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies
5 December, 2025
Alzheimer’s Dement. 2025; 21:e70997
Read the articlePrediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid
2 December, 2025
EMBO Mol Med. 2025 Dec 1. doi: 10.1038/s44321-025-00348-7. Online ahead of print. PMID: 41326715
Read the articleDiagnostic and Prognostic Value of Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta‐Analysis
30 October, 2025
European Journal of Neurology 32, no. 10 (2025): e70382, https://doi.org/10.1111/ene.70382.
Read the articleComplementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer’s disease
15 October, 2025
Alzheimers Dement. 2025 Oct;21(10):e70763. doi: 10.1002/alz.70763. PMID: 41088853
Read the articleCell-weighted polygenic risk scores are associated with β-amyloid and tau biomarkers in Alzheimer’s disease
9 October, 2025
Brain Commun. 2025 Sep 12;7(5):fcaf353. doi: 10.1093/braincomms/fcaf353. eCollection 2025. PMID: 41040848
Read the articlePrimary care detection of Alzheimer’s disease using a self-administered digital cognitive test and blood biomarkers
16 September, 2025
Nat Med. 2025 Dec;31(12):4131-4139. doi: 10.1038/s41591-025-03965-4. Epub 2025 Sep 15. PMID: 40954312
Read the articlePlasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease
15 September, 2025
JAMA Neurol. 2025 Nov 1;82(11):1122-1134. doi: 10.1001/jamaneurol.2025.3217. PMID: 40952756
Read the articleCSF markers of neuroinflammation, synaptic dysfunction and [18F]DOPA-PET in Parkinson’s disease
10 September, 2025
Parkinsonism Relat Disord . 2025 Aug 20:139:108005. doi: 10.1016/j.parkreldis.2025.108005.
Read the articleHemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease
Nature Communications volume 16, Article number: 8232 (2025)
Read the articlePlasma tau biomarkers for biological staging of Alzheimer’s disease
26 August, 2025
Nat Aging. 2025 Nov;5(11):2297-2308. doi: 10.1038/s43587-025-00951-w. Epub 2025 Aug 22. PMID: 40847200
Read the articleTau, atrophy, and domain-specific cognitive impairment in typical Alzheimer’s disease
12 August, 2025
Alzheimer’s & Dementia – The Journal of the Alzheimer’s Association
Read the articleTwo-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification
Nature Communications, Volume 16, Article number: 7182 (2025)
Read the articleComparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
9 July, 2025
acta neuropathol commun 13, 144 (2025). https://doi.org/10.1186/s40478-025-02064-2
Read the articlePrediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study
30 June, 2025
The Lancet Neurology, Volume 24, Issue 7, 591 – 600
Read the articleA comparison of p-tau assays for the specificity to detect tau changes in Alzheimer’s disease
6 May, 2025
Alzheimers Dement. 2025 Apr;21(4):e70208. doi: 10.1002/alz.70208
Read the articlePlasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform
10 April, 2025
Nat Med. 2025 Apr 9. doi: 10.1038/s41591-025-03622-w. Online ahead of print. PMID: 40205199
Read the articlePlasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease
31 March, 2025
Nat Med. 2025 Mar 31. doi: 10.1038/s41591-025-03617-7. Online ahead of print. PMID: 40164726
Read the articlePlasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
28 March, 2025
Nat Aging. 2025 Mar 28. doi: 10.1038/s43587-025-00835-z. Online ahead of print. PMID: 40155777
Read the articleMachine learning prediction of tau‐PET in Alzheimer’s disease using plasma, MRI, and clinical data
4 March, 2025
Alzheimers Dement. 2025 Feb 22;21(2):e14600. doi: 10.1002/alz.14600
Read the article